35.4 F
New York
Friday, February 26, 2021

MediciNova’s [NASDAQ: MNOV] ibudilast Show Promising Result In Alcohol Use Disorder

Must read

MongoDB [NASDAQ: MDB] Announces Extended 5-year Collaboration With Google Cloud

MongoDB Inc. , reported an extended five-year collaboration that will stretch out their current go-to-market relationship. Moreover, it will provide a more profound integration...

Humana Inc [NYSE: HUM] Announces Collaboration With Mercy

Mercy and  Humana Inc. announces that the companies have collaborated. Both the companies inked a contract to extend patient access to virtual healthcare...

International Paper [NYSE: IP] Reports Purchase Of Berkley MF LLC

International Paper has purchased Berkley International's Molded Fiber (Pulp) production subsidiary, Berkley MF LLC. Berkley is the provider of essential packaging and e-commerce...

Perspecta [NYSE: PRSP] Received an Award For $38 Million To Continue Supporting DMDC

Perspecta Inc. , reported that the company has been granted an award to keep supporting the Defense Manpower Data Center (DMDC) with a strategic...

MediciNova, Inc. [NASDAQ: MNOV] disclosed Thursday the result of the Phase 2 trial evaluating MN-166 (ibudilast) for the treatment of Alcohol Use Disorder (AUD).

Principal Investigator, Lara Ray, Ph.D., Professor at the Department of Psychology, University of California Los Angeles (UCLA) has virtually presented the data at the American Psychological Association.

Ibudilast has shown a positive result in Alcohol Use Disorder. A total of 52 alcohol use disorder patients participated in this trial. The trial is a collaborative effort between MediciNova and Dr. Lara Ray and funded by the Center for Study of Opioid Receptors and Drugs of Abuse.

Shares of MediciNova, Inc. soared 2.08% and up +0.13 during the trading of Thursday. Right now, it has day low range of $6.23 and a day high range of $6.45.

Furthermore, MediciNova had a trading volume of 252.31K as compared to the average volume of 1.60 million. If we look at its profitability, its return on assets (ROA) is -14.90%, return on equity (ROE) is -15.70%.

Turning our focus on liquidity, it has a current ratio of 22.00. Likewise, the quick ratio is the same as the current ratio. Currently, MNOV has a total market capitalization of 298.16 million.

In the past 52-weeks of trading, this company’s stocks have fluctuated between the low of $2.79 and a high of $13.25. It has moved up 129.03% from its 52-weeks low and moved down -51.77% from its 52-weeks high.

Ibudilast has decreased the number of heavy drinking days contrasted to the placebo. Furthermore, Patients who were treated with ibudilast and had attenuated VS activation drank the least in the week after the scan. Moreover, there was a significant effect of ibudilast on alcoholic beverage images (ALC).

More articles

Latest article

SG Blocks [NASDAQ: SGBX] Continues Growth Through The Execution Of 19-acre Acquisition Contract

SG Blocks, Inc. executes the contract to purchase the 19 acre Echo sites and all of its multiple structures. The company reported the...

HP Inc [NYSE: HPQ] Enters Into A Contract To Purchase HyperX

HP Inc. revealed that the company entered into a contract to purchase HyperX. It is the gaming subsidiary of Kingston Technology Company. Moreover,...

AT&T [NYSE: T] Might Sell Its Large Minority Stake At Direct TV/ U-Verse Operation To TPG

AT&T is approaching a deal to sell a significant minority stake in its DirecTV, AT&T TV Now, and U-Verse business to TPG. Additionally,...

Wipro [NYSE: WIT] Entered Into A Collaborative Agreement With Uptake

Uptake revealed that the company has collaborated with Wipro limited . The companies inked the agreement to deliver industrial intelligence for the utilities, chemical...

eXp World Holdings [NASDAQ: EXPI] Set Its Footprint In Brazil

eXp World Holdings, Inc. in order to expand its business operations has set its footprint into Brazil, under the eXp Brazil flag. Along...

L3Harris [NYSE: LHX] Grabbed A Contract Totaling Up To $137M For 4 Navigation Payload MDU

L3Harris Technologies announced that the company has grabbed a contract that totals up to $137 million for four route payload Mission Data Units...

VerifyMe [NASDAQ: VRME] Nabs Purchase Order For 2M Pre-Printed Anti-Counterfeiting Labels

VerifyMe, Inc revealed that the company has been awarded an initial purchase order for PPE anti-counterfeit technology. The company obtained a request for...

NeoGames [NASDAQ: NGMS] Announces The Go-Live Of Its Games With Austrian Lotteries

NeoGames S.A. expands further into the European lottery market by launching its first set of games. The company revealed that it signed an...